Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan Herrmann

Showing results (141-150 of 470) with videos related to

Pageof 47
Sort By:
Journal of Clinical Psychopharmacology|June 27, 2003
Acute pharmacological effects of temazepam, diphenhydramine, and valerian in healthy elderly subjectsJennifer R Glass, Beth A Sproule, Nathan Herrmann, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|February 26, 2010
Efficacy and tolerability of antidepressants for treatment of depression in coronary artery disease: a meta-analysisYekta Dowlati, Nathan Herrmann, Walter L Swardfager, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|January 11, 2007
Epidemiology of social phobia in later lifeJohn Cairney, Laura McCabe, Scott Veldhuizen, et al.
The Cochrane Database of Systematic Reviews|February 18, 2011
Antidepressants for agitation and psychosis in dementiaDallas P Seitz, Nikesh Adunuri, Sudeep S Gill, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|November 30, 2011
At-fault motor vehicle crash risk in elderly patients treated with antidepressantsMark J Rapoport, Brandon Zagorski, Dallas Seitz, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|September 28, 2011
Determining the impact of dementia on antidepressant treatment response in older adultsCorinne E Fischer, Tom A Schweizer, Jemcy Joy, et al.
Expert Opinion on Drug Safety|October 17, 2022
Risks and benefits of current and novel drugs to treat agitation in Alzheimer's diseaseNathan Herrmann, Hui Jue Wang, Bing Xin Song, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|December 22, 2010
The relation between disease severity and cost of caring for patients with Alzheimer disease in CanadaNathan Herrmann, Derrick Y Tam, Robert Balshaw, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|September 15, 2004
Canadian Outcomes Study in Dementia: study methods and patient characteristicsRobert Sambrook, Nathan Herrmann, Réjean Hébert, et al.
International Journal of Geriatric Psychiatry|March 2, 2011
Detection and treatment of post stroke depression: results from the registry of the Canadian stroke networkNathan Herrmann, Dallas Seitz, Hadas Fischer, et al.
Pageof 47

Showing results (141-150 of 470) with videos related to

Sort By:
Pageof 47
Journal of Clinical Psychopharmacology|June 27, 2003
Acute pharmacological effects of temazepam, diphenhydramine, and valerian in healthy elderly subjectsJennifer R Glass, Beth A Sproule, Nathan Herrmann, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|February 26, 2010
Efficacy and tolerability of antidepressants for treatment of depression in coronary artery disease: a meta-analysisYekta Dowlati, Nathan Herrmann, Walter L Swardfager, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|January 11, 2007
Epidemiology of social phobia in later lifeJohn Cairney, Laura McCabe, Scott Veldhuizen, et al.
The Cochrane Database of Systematic Reviews|February 18, 2011
Antidepressants for agitation and psychosis in dementiaDallas P Seitz, Nikesh Adunuri, Sudeep S Gill, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|November 30, 2011
At-fault motor vehicle crash risk in elderly patients treated with antidepressantsMark J Rapoport, Brandon Zagorski, Dallas Seitz, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|September 28, 2011
Determining the impact of dementia on antidepressant treatment response in older adultsCorinne E Fischer, Tom A Schweizer, Jemcy Joy, et al.
Expert Opinion on Drug Safety|October 17, 2022
Risks and benefits of current and novel drugs to treat agitation in Alzheimer's diseaseNathan Herrmann, Hui Jue Wang, Bing Xin Song, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|December 22, 2010
The relation between disease severity and cost of caring for patients with Alzheimer disease in CanadaNathan Herrmann, Derrick Y Tam, Robert Balshaw, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|September 15, 2004
Canadian Outcomes Study in Dementia: study methods and patient characteristicsRobert Sambrook, Nathan Herrmann, Réjean Hébert, et al.
International Journal of Geriatric Psychiatry|March 2, 2011
Detection and treatment of post stroke depression: results from the registry of the Canadian stroke networkNathan Herrmann, Dallas Seitz, Hadas Fischer, et al.
Pageof 47